Complete Exam Guide Subject-wise practice platform
Gastrointestinal Drugs

Proton Pump Inhibitors Practice Questions

20 free Proton Pump Inhibitors practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Proton Pump Inhibitors questions

20 questions
  1. Q1. Which of the following enzymes is the direct target of Proton Pump Inhibitors (PPIs)?
  2. Q2. PPIs are administered as inactive prodrugs. In which environment are they converted to their active sulfenamide form?
  3. Q3. What type of chemical bond do PPIs form with the cysteine residues of the H+/K+ ATPase pump?
  4. Q4. To ensure maximal efficacy, when should a delayed-release oral PPI typically be administered?
  5. Q5. Which of the following PPIs is the S-enantiomer of Omeprazole and typically exhibits slower hepatic clearance?
  6. Q6. Long-term use of PPIs has been associated with an increased risk of which gastrointestinal infection?
  7. Q7. Which of the following electrolytes is most commonly depleted with chronic, high-dose PPI therapy, potentially leading to tetany or arrhythmias?
  8. Q8. PPIs may reduce the absorption of which vitamin that requires gastric acid for its release from dietary proteins?
  9. Q9. Why is there a potential drug interaction between Omeprazole and the antiplatelet drug Clopidogrel?
  10. Q10. Which of the following is an FDA-approved clinical indication for PPIs?
  11. Q11. Chronic PPI use is associated with a 'rebound' effect if stopped abruptly. This is caused by an increase in which hormone?
  12. Q12. Which PPI has the most rapid conversion to its active form across a wider range of pH levels, potentially offering a faster onset of action?
  13. Q13. Patients on long-term PPI therapy may have a slightly increased risk of hip, wrist, and spine fractures due to decreased absorption of:
  14. Q14. Which of the following is a symptom of Zollinger-Ellison Syndrome, for which PPIs are the treatment of choice?
  15. Q15. How do PPIs differ from H2-receptor antagonists (H2RAs) in terms of efficacy?
  16. Q16. In the context of the 'Triple Therapy' for H. pylori, which of the following is typically combined with a PPI?
  17. Q17. Which PPI is available as an intravenous formulation for the management of acute upper gastrointestinal bleeding?
  18. Q18. What is the primary route of elimination for most Proton Pump Inhibitors?
  19. Q19. A patient with Gastroesophageal Reflux Disease (GERD) fails to respond to once-daily PPI. What is the most common next step in pharmacological management?
  20. Q20. PPI use should be carefully monitored in patients with liver cirrhosis because: